A detailed history of Gibbs Wealth Management transactions in Insulet Corp stock. As of the latest transaction made, Gibbs Wealth Management holds 720 shares of PODD stock, worth $239,544. This represents 0.05% of its overall portfolio holdings.

Number of Shares
720
Previous 703 2.42%
Holding current value
$239,544
Previous $217 Million 4.11%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 23, 2026

BUY
$305.98 - $336.84 $5,201 - $5,726
17 Added 2.42%
720 $208 Million
Q3 2025

Oct 30, 2025

SELL
$277.3 - $352.82 $63,501 - $80,795
-229 Reduced 24.57%
703 $217 Million
Q2 2025

Aug 13, 2025

BUY
$238.57 - $327.47 $222,347 - $305,202
932 New
932 $293 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $23.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Gibbs Wealth Management Portfolio

Follow Gibbs Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gibbs Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Gibbs Wealth Management with notifications on news.